RSS | Login | Register

Pricing

Company news: Corcept Therapeutics and Daiichi Sankyo

March 23, 2012

Corcept Therapeutics said its Cushing's syndrome drug will be launched three weeks earlier than expected.

In the long run, reforms mean less risk, lower rewards for pharmas

Matthew Arnold March 23, 2010

In broad strokes, the healthcare reform bill that the president signed this noon holds much the same promise for pharmas as an SSRI does for depression or bipolar patients: less high highs, less low lows, more certainty and stability.

Aging Committee raps pharma on brand drug price hikes

Ben Comer March 18, 2010

Armed with AARP and Kaiser Family research, members of the Senate Special Committee on Aging asked panelists why brand drug prices in the US continue to increase, while other countries pay half as much for the same products.

Sharp Rx price jumps way up, says GAO

Matthew Arnold January 12, 2010

A Government Accountability Office study found "extraordinary price increases" in 416 branded drug products (across 321 brands) between 2000 and 2008. That's about half of one percent of all branded drug products.

Video Exclusive

Web Exclusives

Five industry experts advise specialty pharma company on digital strategy

April 20, 2012

Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.